Cholesterol · Patient guide
What is inclisiran?
Inclisiran is a prescription small-interfering RNA therapy that lowers LDL cholesterol by reducing production of PCSK9 and is considered within a clinician-directed lipid plan.
The short answer
Inclisiran is a prescription small-interfering RNA therapy that lowers LDL cholesterol by reducing production of PCSK9 and is considered within a clinician-directed lipid plan.
The meaning of a symptom, test, or diagnosis depends on the person’s history and complete clinical picture. A cardiovascular clinician can determine whether additional evaluation is appropriate.
How PICC approaches the question
PICC begins with the clinical problem, reviews prior information, and selects testing only when it can answer a meaningful question. Care stays connected across prevention, diagnosis, treatment, and follow-up.
Related PICC programAdvanced Lipid ClinicExplore program →Questions to bring to your visit
- What information from my prior tests is most useful?
- What clinical question would another test answer?
- How would the result change my care plan?
- What symptoms should prompt urgent evaluation?
- How does prevention fit into my next step?